VR Adviser as of March 31, 2024
Portfolio Holdings for VR Adviser
VR Adviser holds 38 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apogee Therapeutics (APGE) | 26.8 | $564M | 8.5M | 66.45 | |
| 4d Molecular Therapeutics In (FDMT) | 6.7 | $140M | 4.4M | 31.86 | |
| Ocular Therapeutix (OCUL) | 5.5 | $116M | 13M | 9.10 | |
| Spyre Therapeutics Com New (SYRE) | 3.9 | $82M | 2.2M | 37.93 | |
| Merus N V (MRUS) | 3.8 | $81M | 1.8M | 45.03 | |
| Pharvaris N V (PHVS) | 3.7 | $79M | 3.4M | 23.11 | |
| Kalvista Pharmaceuticals (KALV) | 3.5 | $74M | 6.2M | 11.86 | |
| Enliven Therapeutics (ELVN) | 3.4 | $71M | 4.0M | 17.59 | |
| Miragen Therapeutics (VRDN) | 3.2 | $68M | 3.9M | 17.51 | |
| Dianthus Therapeutics (DNTH) | 3.0 | $63M | 2.1M | 30.00 | |
| Dyne Therapeutics (DYN) | 2.9 | $62M | 2.2M | 28.39 | |
| Applied Therapeutics (APLT) | 2.9 | $62M | 9.1M | 6.80 | |
| Oric Pharmaceuticals (ORIC) | 2.9 | $60M | 4.4M | 13.75 | |
| Astria Therapeutics (ATXS) | 2.4 | $51M | 3.6M | 14.07 | |
| Mersana Therapeutics (MRSN) | 2.4 | $51M | 11M | 4.48 | |
| Engene Holdings (ENGN) | 2.1 | $44M | 2.6M | 16.95 | |
| Praxis Precision Medicines I Com New (PRAX) | 2.0 | $43M | 706k | 61.02 | |
| Hillevax (HLVX) | 1.6 | $35M | 2.1M | 16.63 | |
| Cogent Biosciences (COGT) | 1.6 | $35M | 5.1M | 6.72 | |
| Edgewise Therapeutics (EWTX) | 1.6 | $33M | 1.8M | 18.24 | |
| Cabaletta Bio (CABA) | 1.3 | $27M | 1.6M | 17.06 | |
| Arvinas Ord (ARVN) | 1.2 | $26M | 628k | 41.28 | |
| Taysha Gene Therapies Com Shs (TSHA) | 1.2 | $26M | 9.0M | 2.87 | |
| Aquestive Therapeutics (AQST) | 1.1 | $24M | 5.6M | 4.26 | |
| Terns Pharmaceuticals (TERN) | 1.1 | $22M | 3.4M | 6.56 | |
| Adverum Biotechnologies Com New (ADVM) | 1.0 | $22M | 1.6M | 14.14 | |
| Celcuity (CELC) | 1.0 | $21M | 970k | 21.60 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.9 | $19M | 1.3M | 14.30 | |
| Immatics SHS (IMTX) | 0.9 | $18M | 1.8M | 10.51 | |
| Lyra Therapeutics (LYRA) | 0.8 | $16M | 2.6M | 6.22 | |
| Cg Oncology (CGON) | 0.7 | $15M | 350k | 43.90 | |
| Century Therapeutics (IPSC) | 0.7 | $14M | 3.4M | 4.18 | |
| Trevi Therapeutics (TRVI) | 0.6 | $12M | 3.4M | 3.45 | |
| Tenaya Therapeutics (TNYA) | 0.4 | $8.1M | 1.6M | 5.23 | |
| Mineralys Therapeutics (MLYS) | 0.3 | $7.2M | 556k | 12.91 | |
| Acelyrin (SLRN) | 0.3 | $6.3M | 937k | 6.75 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.2 | $5.2M | 250k | 20.67 | |
| Olema Pharmaceuticals (OLMA) | 0.0 | $872k | 77k | 11.32 |
